Omar Qureshi, DO
Interventional Pain Medicine · Fitchburg, MANPI 1760776892
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 74.5% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $1,494, 9.4 times the $159 reported in 2019.
Across 174 payments — averaging $37.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Alkermes, Inc.$267
- Lilly USA, LLC$242
- Fidia Pharma USA Inc.$210
- Abbott$158
- Indivior Inc.$128
- plus $671 from 17 others
What the payments were for
- Food & beverage$6,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 94 | $4,894 |
| Alkermes, Inc. | 14 | $267 |
| Lilly USA, LLC | 15 | $242 |
| Fidia Pharma USA Inc. | 9 | $210 |
| Abbott | 3 | $158 |
| Indivior Inc. | 5 | $128 |
| Valinor Pharma, LLC | 6 | $123 |
| Globus Medical | 5 | $111 |
| Lundbeck LLC | 3 | $75 |
| Vertos Medical, Inc. | 2 | $58 |
| Scilex Pharmaceuticals Inc. | 3 | $40 |
| Biodelivery Sciences International, Inc. | 2 | $36 |
| Pfizer | 2 | $35 |
| Shionogi Inc | 2 | $27 |
| Painteq LLC | 1 | $25 |
| Si-bone, Inc. | 1 | $24 |
| Curonix LLC | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Nalu Medical, Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Novartis | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,571 in reported general payments places this provider in the 75th percentile of 22 interventional pain medicine providers in Massachusetts.
See all interventional pain medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $1,425 |
| Pregabalin | 43 | $476 |
| Gabapentin | 40 | $391 |
| Cyclobenzaprine Hcl | 24 | $237 |
| Duloxetine Hcl | 13 | $231 |
| Topiramate | 20 | $187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $94 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $79 |
| Tizanidine Hcl | 14 | $72 |
| Tramadol Hcl | 23 | $55 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Fitchburg
- Warren Mackie-JenkinsBoston$65K
- Mark JonesBoston$48K
- Frederic GergesBoston$21K
- David DibenedettoWaltham$17K
- Anil KumarStoneham$8K
- Rami RustumMethuen$6K
- Janet PearlFramingham$5K
- Yuri KhibkinHolyoke$5K
- Erica BialBurlington$5K
- Elvis GuzmanBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.